Article info
PDFOriginal research
Drug repurposing as a potential source of innovative therapies in cervical cancer
- Correspondence to Dr Rica Capistrano I., Anticancer Fund, Meise, Belgium; rica.capistrano{at}anticancerfund.org
Citation
Drug repurposing as a potential source of innovative therapies in cervical cancer
Publication history
- Received April 22, 2022
- Accepted August 19, 2022
- First published September 22, 2022.
Article Versions
- You are currently viewing a Previous version of this article (22 September 2022).
- View the most recent version of this article
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2022. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, an indication of whether changes were made, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.